newsmaker

AMG Critical Materials Signs Letter of Intent to Repurchase 40% Stake in its Subsidiary Graphit Kropfmühl

AMG Signs Letter of Intent to Repurchase 40% Ownership Interest in GK Company Announcement Amsterdam, 23 December 2024 AMG Critical Materials N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) has announced the signing of a letter of intent to repurchase a 40% ownership interest in Graphit Kropfmühl GmbH (“GK”) currently owned by Alterna Capital Partners (“Alterna”). The purchase…

Read More

Millicom Tigo Announces Share Repurchase Activity for 2024: A Strategic Move Towards Growth and Stability

Millicom (Tigo) Share Repurchase Activity December 23, 2024 On November 29, 2024, Millicom announced a share repurchase program, and between December 16, 2024, and December 20, 2024, the company repurchased 455,000 of its Swedish Depository Receipts (SDRs). The details of the repurchase activity are outlined below: Trade Date Number of SDRs Repurchased Daily Average Price…

Read More

RAPT Therapeutics: Big Bucks Alert! $150 Million Private Placement Announced for 2024

RAPT Therapeutics Announces Private Placement of Common Stock Exciting News in the Biotech World SOUTH SAN FRANCISCO, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing novel therapies for patients with significant unmet needs in inflammatory diseases, today announced that it…

Read More

Get Ready for a Refresh: The Container Store’s Exciting Recapitalization Plan to Set the Stage for Future Success!

COPPELL, Texas–(BUSINESS WIRE)–The Container Store Group, Inc. A Fresh Start for The Container Store Let’s talk about that moment when you open up your closet and it looks like a tornado just passed through. Clothes everywhere, shoes piled on top of each other, and no sense of organization in sight. Sound familiar? Well, fear not…

Read More

Investor Alert: Bronstein, Gewirtz & Grossman LLC Announces Opportunity for Kyverna Therapeutics Inc. Investors with Substantial Losses to Lead Class Action Lawsuit

Class Action Lawsuit Filed Against Kyverna Therapeutics, Inc. NEW YORK, Dec. 22, 2024 /PRNewswire/ — Attorney Advertising Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ: KYTX) and certain of its officers. This lawsuit seeks…

Read More